Total Payments
$7,322
2024 Payments
$29.32
Companies
35
Transactions
373
Medicare Patients
658
Medicare Billing
$103,803
Payment Breakdown by Category
Food & Beverage$7,316 (99.9%)
Education$6.47 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,316 | 371 | 99.9% |
| Education | $6.47 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,634 | 79 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $669.56 | 46 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $478.06 | 28 | $0 (2022) |
| Alkermes, Inc. | $413.46 | 15 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $379.55 | 20 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $369.75 | 21 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $361.13 | 19 | $0 (2023) |
| Neuronetics, Inc. | $312.06 | 10 | $0 (2021) |
| Bausch Health US, LLC | $305.46 | 16 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $302.95 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.32 | 1 | ABBVIE INC. ($29.32) |
| 2023 | $1,275 | 55 | AbbVie Inc. ($581.88) |
| 2022 | $1,426 | 72 | ABBVIE INC. ($396.31) |
| 2021 | $1,612 | 86 | AbbVie Inc. ($626.02) |
| 2020 | $691.39 | 39 | Allergan, Inc. ($82.69) |
| 2019 | $1,078 | 43 | Neuronetics, Inc. ($217.57) |
| 2018 | $810.83 | 44 | Vanda Pharmaceuticals Inc. ($179.36) |
| 2017 | $400.55 | 33 | Janssen Pharmaceuticals, Inc ($162.77) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Neurology | ||||||
| 09/27/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/13/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/29/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: PSYCHOLOGY | ||||||
| 08/23/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: CNS | ||||||
| 08/22/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Central Nervous System | ||||||
| 08/11/2023 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: ADHD | ||||||
| 08/01/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/26/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: PSYCHIATRY | ||||||
| 07/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: PSYCHIATRY | ||||||
| 06/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/20/2023 | Validus Pharmaceuticals LLC | Equetro (Drug) | Food and Beverage | Cash or cash equivalent | $34.82 | General |
| Category: CNS | ||||||
| 06/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 59 | $17,927 | $4,578 |
| 2022 | 5 | 225 | 450 | $64,413 | $27,728 |
| 2021 | 5 | 293 | 615 | $97,975 | $52,916 |
| 2020 | 3 | 126 | 317 | $42,645 | $18,581 |
Total Patients
658
Total Services
1,441
Medicare Billing
$103,803
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 59 | $17,927 | $4,578 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 264 | $46,296 | $19,471 | 42.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 37 | 83 | $10,032 | $4,607 | 45.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 26 | $5,720 | $2,747 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,375 | $716.40 | 52.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 46 | 66 | $990.00 | $186.92 | 18.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 327 | $57,225 | $30,521 | 53.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 105 | $23,100 | $15,084 | 65.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 33 | 33 | $11,550 | $5,624 | 48.7% |
| 96136 | Psychological or neuropsychological test administration and scoring by qualified health care professional, first 30 minutes | Office | 2021 | 34 | 35 | $4,375 | $1,265 | 28.9% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 63 | 115 | $1,725 | $422.91 | 24.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 204 | $30,625 | $13,122 | 42.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 72 | $7,920 | $3,180 | 40.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 22 | 41 | $4,100 | $2,279 | 55.6% |
About Ryan Deen
Ryan Deen is a Psychiatry healthcare provider based in Ocoee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1164799037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Deen has received a total of $7,322 in payments from pharmaceutical and medical device companies, with $29.32 received in 2024. These payments were reported across 373 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,316).
As a Medicare-enrolled provider, Deen has provided services to 658 Medicare beneficiaries, totaling 1,441 services with total Medicare billing of $103,803. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Ocoee, FL
- Active Since 11/21/2011
- Last Updated 10/12/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1164799037
Products in Payments
- VRAYLAR (Drug) $1,919
- LATUDA (Drug) $478.06
- INVEGA SUSTENNA (Drug) $349.12
- SPRAVATO (Drug) $319.54
- REXULTI (Drug) $317.38
- NEUROSTAR TMS THERAPY (Device) $312.06
- APLENZIN (Drug) $286.20
- ARISTADA (Drug) $239.84
- Fanapt (Drug) $206.89
- Trintellix (Drug) $193.41
- NUEDEXTA (Drug) $185.76
- Nuedexta (Drug) $178.38
- HETLIOZ (Drug) $172.66
- TRINTELLIX (Drug) $167.72
- Adzenys XR-ODT (Drug) $149.63
- INGREZZA (Drug) $136.45
- SUNOSI (Drug) $130.29
- Azstarys (Drug) $129.63
- ABILIFY MAINTENA (Drug) $128.76
- CAPLYTA (Drug) $116.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Ocoee
Hanish Sethi, Md, MD
Psychiatry — Payments: $3,596
Psychiatry $3,596
Eric Downes, M.d, M.D
Psychiatry — Payments: $996.16
Psychiatry $996.16
Manvir Dhillon, Md, MD
Psychiatry — Payments: $928.71
Psychiatry $928.71
Dr. Kazi Ahmad, Md, MD
Psychiatry — Payments: $904.71
Psychiatry $904.71
Harsh Patel, Md, MD
Psychiatry — Payments: $39.71
Psychiatry $39.71